自然杀伤细胞在肿瘤免疫治疗中的研究进展  

Progress in Immunotherapy of NK Cells for Human Cancer

作　　者：刘佳[1] 王全立[1] 

机构地区：[1]军事医学科学院附属医院输血科,北京100071

出　　处：《现代生物医学进展》2009年第5期954-956,共3页Progress in Modern Biomedicine

基　　金：国家自然科学基金(30772457)

摘　　要：NK细胞作为抗体依赖细胞毒作用的效应器,在抗肿瘤免疫中发挥着重要作用,成为目前肿瘤免疫治疗的研究热点。本文就NK细胞抗肿瘤免疫治疗的策略,治疗的关键性问题、及与其他方法联合治疗等的研究现状进行综述。NK cells, as the effectors in antibody-dependent cell- mediated cytotoxicity, play important roles in anti-tumor immune response. They now have become the hot point in the study on tumor immunotherapy. This paper has summarized the present research situation on the strategies for NK-cell therapy, the crucial issues for NK-cell-based therapy and the combinatorial therapies for human caner.

关 键 词：自然杀伤细胞 肿瘤 免疫治疗 

分 类 号：R392.12[医药卫生—免疫学] R730.1[医药卫生—基础医学]